SPY415.87+4.42 1.07%
DIA340.44+2.91 0.86%
IXIC14,038.76+180.92 1.31%

DJ Merck Gets EU Approval for Keytruda in Classical Hodgkin Lymphoma >MRK

· 03/17/2021 07:17

Please log in to view news